These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4930446)

  • 41. Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds.
    Knothe H
    Infection; 1977; 5(3):137-9. PubMed ID: 914361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
    Dutta GN; Devriese LA
    Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rarity of tylosin resistance in human pathogenic bacteria.
    Lacey RW
    Vet Rec; 1988 Apr; 122(18):438-9. PubMed ID: 3293307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo differentiation of yeast cytoplasmic and mitochondrial protein synthesis with antibiotics.
    Clark-Walker GD; Linnane AW
    Biochem Biophys Res Commun; 1966 Oct; 25(1):8-13. PubMed ID: 5971759
    [No Abstract]   [Full Text] [Related]  

  • 45. Bacteriophage P13234mo-mediated intra- and intergroup transduction of antibiotic resistance among streptococci.
    Malke H; Starke R; Köhler W; Kolesnichenko G; Totolian AA
    Zentralbl Bakteriol Orig A; 1975 Sep; 233(1):24-34. PubMed ID: 128266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.
    Sanders E; Foster MT; Scott D
    N Engl J Med; 1968 Mar; 278(10):538-40. PubMed ID: 4966066
    [No Abstract]   [Full Text] [Related]  

  • 47. Susceptibility of Mycoplasma pneumoniae to antibiotics in vitro.
    Niitu Y; Kubota H; Hasegawa S; Komatsu S; Horikawa M
    Jpn J Microbiol; 1974 Mar; 18(2):149-55. PubMed ID: 4473656
    [No Abstract]   [Full Text] [Related]  

  • 48. Characterization of the antibiotic resistance plasmid ERL1 from Streptococcus pyogenes.
    Malke H; Jacob HE; Störl K
    Mol Gen Genet; 1976 Mar; 144(3):333-8. PubMed ID: 775302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.
    Perez-Trallero E; Marimón JM; Montes M; Orden B; de Pablos M
    Emerg Infect Dis; 1999; 5(2):235-40. PubMed ID: 10221875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sensitivities of clinical isolates to lincomycin and macrolide-type antibiotics (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1981 Mar; 34(3):419-24. PubMed ID: 7289033
    [No Abstract]   [Full Text] [Related]  

  • 52. Group A Streptococcus resistant to erythromycin and lincomycin.
    Dixon JM
    Can Med Assoc J; 1968 Dec; 99(22):1093-4. PubMed ID: 4386993
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasmid-determined resistance to erythromycin: comparison of strains of streptococcus faecalis and streptococcus pyogenes with regard to plasmid hmology and resistance inducibility.
    Yag Y; Franke AE; Clewell DB
    Antimicrob Agents Chemother; 1975 Jun; 7(6):871-3. PubMed ID: 808161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative erythromycin resistance in Streptococcus pyogenes.
    Botha P
    S Afr Med J; 1990 May; 77(9):486-7. PubMed ID: 2187256
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antibacterial activity in vitro of a new rifamycin: rifamide].
    Monnier J; Bourse R
    Pathol Biol; 1968 Oct; 16(19):901-8. PubMed ID: 4972879
    [No Abstract]   [Full Text] [Related]  

  • 56. Mutant of Staphylococcus aureus with lincomycin- and carbomycin-inducible resistance to erythromycin.
    Tanaka T; Weisblum B
    Antimicrob Agents Chemother; 1974 May; 5(5):538-40. PubMed ID: 4462467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Feb; 1(1):35-8. PubMed ID: 2656930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Streptococcus pyogenes erythromycin resistance in Italy.
    Bassetti M; Mantero E; Gatti G; Di Biagio A; Bassetti D
    Emerg Infect Dis; 1999; 5(2):302-3. PubMed ID: 10221991
    [No Abstract]   [Full Text] [Related]  

  • 59. [Streptococcus pyogenes group A--sensitivity to chemical preparations in vitro].
    Výmola F; Jedlicková Z
    Cas Lek Cesk; 1972 Mar; 111(13):292-4. PubMed ID: 4552005
    [No Abstract]   [Full Text] [Related]  

  • 60. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
    Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.